In vitro drug release

The eye presents unique opportunities and challenges for the delivery of pharmaceutical dosage forms. Ocular inserts of Moxifloxacin HCl were prepared with the objective of reducing frequency of administration, controlled release and greater therapeutic effect. Moxifloxacin HCl a broad spectrum fourth generation fluroquinolone used in the treatment of conjunctivitis, keratitis, kerato-conjunctivitis etc. In the present wok reservoir type of ocular inserts formulated by sandwiching poly vinyl alcohol containing Moxifloxacin HCl in between two rate controlling membranes of ethyl cellulose and PVP-K30. The reservoir types of ocular inserts containing Moxifloxacin HCl were formulated by film casting technique using PVA as drug reservoir polymer and EC: PVP-K30 as a rate controlling material. In vitro drug release revealed that the optimized (FM6) formulation showed a controlled release. In vivo studies showed a release of 97.67% over a period of 5 days with high correlation coefficient  of  In vitro-In vivo release studies. In the present study the ocular inserts of Moxifloxacin HCl (FM6) provided desired drug release for 5 days and remained stable.

In the present investigation, pH-dependent and controlled drug release polymeric microspheres of Ornidazole were developed to deliver the active molecule to the colonic region. Microspheres were prepared by emulsion cross-linking method with some modifications, using different proportions of Ornidazole and Polymers (guar gum and gelatin). Gelatin microspheres were coated with Acrycoat L100 to achieve pH sensitive properties and specific biodegradability for colon targeted delivery of Ornidazole. Microspheres were evaluated for size, morphology, sphericity study, % yield, loose surface crystal study, drug content and entrapment efficiency. In vitro drug release study was conducted by buffer change method to mimic GIT environment using buffer solutions of varying pH. The investigations revealed that microspheres prepared with Ornidazole: guar gum ratio (1:2) shows only 10.003±0.885 % drug was released in first 5 hours and 38.849 ± 0.62 % in 12 hours, which proves the potentiality of guar gum for colonic delivery of drugs. While for microspheres prepared with Ornidazole: gelatin (1:2) and coated with Arycoat L100 shows 16.596 ± 3.18 % drug release in first 5 hours and 45.921 ± 3.07 % in 12 hours. Key Words: colon specific drug delivery, biodegradable polymers, pH-dependent release, In vitro drug release